trial

Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study

NCTId NCT00350935
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 52 (estimated)
Sponsored by University Hospital, Strasbourg, France
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
52 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2006-09
Primary completion
—
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
fMRI

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor
Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
Centre National de la Recherche Scientifique, FranceCollaborator
Région AlsaceCollaborator
Faculté de Médecine de StrasbourgCollaborator

Investigators

1
Anne GIERSCH, MD, PhDPrincipal Investigator

Sites

1 total
Strasbourg, France

Facts & assertions

3 sourced
Enrollment
52
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
fMRI
drug
lead_sponsor
University Hospital, Strasbourg, France
company
collaborator
Institut National de la Santé Et de la Recherche Médicale, France
company
Centre National de la Recherche Scientifique, France
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Anne GIERSCH, MD, PhD
person